| 摘要 |
Use of a substance that upon administration to a patient leads to an increased level of a growth hormone receptor antagonist, and in particular use of a growth hormone receptor antagonist, for the production of a pharmaceutical composition for treatment of hypertrophic cardiomyopathy is disclosed. A method for treatment of hypertrophic cardiomyopathy, wherein a pharmaceutically effective amount of the above mentioned substance is administered to a patient is also disclosed. |
